What is DAN's health score?

DANA Inc (DAN) has a TradeApes health score of 67 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is DAN's estimated fair value?

Based on our 5-year discounted cash flow model, DANA Inc's estimated fair value is $42.27 per share, representing a 19.4% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is DAN undervalued or overvalued?

Our model currently rates DAN as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for DAN... Refresh in a moment for the full analysis.

DANA Inc (DAN)

Consumer Cyclical Fair Value low healthy

$35.41

Updated: 2026-05-30

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

50 Mixed

Relative Value

95 Strong

Capital Allocation

65 Healthy

Risk

70 Healthy

Est. Fair Value $42.27

DCF Upside +19.4%

Sector Rank #770 of 3121

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.